Back

Directional deconvolution of spatial conductance proxies resolves prognostic signal cancellation in oral squamous cell carcinoma

Tang, K.; Huang, Y.; Chen, M.

2026-05-12 oncology
10.64898/2026.05.08.26351944 medRxiv
Show abstract

BackgroundTumor cells are increasingly understood as physically connected collectives whose intercellular communication is gated by gap junctions and modulated by microen-vironmental ion fluxes. While spatial transcriptomics provides the geometric substrate for building transcriptomic proxies of bioelectric organization, no robust pipeline currently translates spot-level connectivity features into independent clinical prognostic markers. MethodsWe analyzed 12 oral squamous cell carcinoma (OSCC) Visium sections (GSE208253). A K-nearest-neighbor (K=6) spatial graph was built on full-resolution coordinates and edge-weighted by a conductance-like transcriptomic proxy in which gap-junction proxy expression was scaled by an exponential acid-gating penalty. Geometric edge artefacts were controlled with concave-hull edge distance and partial rank correlation under permutation testing. A 25-gene BCI-Signature was extracted by intra-sample top/bottom conductance differential expression and cross-sample consensus voting ([≥] 6/12). The signature was spatially back-projected, directionally decomposed from prior biology, and then projected to TCGA-HNSC (n = 519) and GSE65858 (n = 270) for survival analysis. Cohort-level effects were combined by inverse-variance fixed-effect meta-analysis. ResultsDiagnostic controls falsified the initial isolation-driven hypothesis: across all 12 sections, the partial rank correlation between the isolation index and depolarization-footprint expression was negative after edge-distance adjustment. Feature ablation identified the conductance sum as the best transcriptomic proxy of physical network state, and section-level sensitivity analyses preserved the positive conductance-stress direction after long-edge removal and graph-parameter perturbation. Spatial back-projection showed that aggressive and differentiation programs are positively correlated within every section (median{rho} = 0.43) and co-enrich in high-conductance regions. This predicted bulk-level signal cancellation: the unweighted 25-gene mean was non-prognostic in TCGA-HNSC (HR=1.17, p=0.35), whereas the locked directional composite BCI_net was independently associated with worse OS (HR=1.38, 95% CI 1.06-1.79, p=0.015 after adjustment for age, stage, HPV status and gender). The effect persisted after separate adjustment for composition, EMT and proliferation proxies, but attenuated in a saturated all-proxy benchmark model. The biologically matched HPV-negative oral-cavity subset of GSE65858 (n = 77) preserved the direction with a larger effect size (HR=2.45, 95% CI 0.96-6.27, p=0.062). Inverse-variance fixed-effect pooling of the two cohorts yielded a significant pooled effect (HR=1.48, 95% CI 1.07-2.05, p=0.019). ConclusionsSpatial graph features can be transferred to bulk transcriptomic cohorts only after the structural and aggressive programs that co-localize within the same physical network are explicitly deconvolved. The equal-weight directional metric BCI_net is a biology-driven candidate prognostic readout that remains preliminary pending broader independent validation.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 2%
23.2%
2
Clinical Cancer Research
58 papers in training set
Top 0.2%
6.6%
3
Cancer Cell
38 papers in training set
Top 0.2%
6.5%
4
Nature Genetics
240 papers in training set
Top 2%
3.8%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 19%
3.7%
6
Cancer Discovery
61 papers in training set
Top 0.7%
3.2%
7
Genome Biology
555 papers in training set
Top 3%
3.0%
8
Journal of Clinical Investigation
164 papers in training set
Top 2%
2.8%
50% of probability mass above
9
Cell Reports Medicine
140 papers in training set
Top 2%
2.4%
10
Science
429 papers in training set
Top 12%
2.4%
11
Cell Reports
1338 papers in training set
Top 20%
2.1%
12
eBioMedicine
130 papers in training set
Top 0.7%
2.1%
13
Scientific Reports
3102 papers in training set
Top 48%
2.1%
14
iScience
1063 papers in training set
Top 9%
2.1%
15
Nature Cancer
35 papers in training set
Top 0.7%
1.8%
16
eLife
5422 papers in training set
Top 40%
1.7%
17
BMC Medicine
163 papers in training set
Top 3%
1.7%
18
The EMBO Journal
267 papers in training set
Top 3%
1.3%
19
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.7%
1.0%
20
Cancers
200 papers in training set
Top 4%
1.0%
21
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
22
Nature
575 papers in training set
Top 14%
0.9%
23
Journal of Translational Medicine
46 papers in training set
Top 2%
0.9%
24
Communications Biology
886 papers in training set
Top 20%
0.8%
25
British Journal of Cancer
42 papers in training set
Top 1%
0.8%
26
Cancer Research
116 papers in training set
Top 3%
0.8%
27
Frontiers in Oncology
95 papers in training set
Top 4%
0.7%
28
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.4%
0.7%
29
Molecular Cancer
14 papers in training set
Top 1%
0.7%
30
European Journal of Cancer
10 papers in training set
Top 0.6%
0.7%